Adamis Pharma prices public offering of 3.72 mln shares of common stock at $5.95 per share; announces listing on NASDAQ, reverse stock split (ADMP) : In connection with the offering, Adamis has completed a 1-for-17 reverse stock split of its common stock which is effective as of December 13, 2013. The common stock began trading, on a split-adjusted basis, on The NASDAQ Capital Market under the symbol "ADMP" on December 13, 2013. In connection with its listing on The NASDAQ Capital Market, the company's common stock will cease trading on the OTC QB.